Try Ask OE! Our NEW Advanced AI Enabled Search
Dive into the Largest Database of
Musculoskeletal Evidence
ACE Reports.
Osteoarthritis
Treatment of symptomatic knee osteoarthritis with oral salmon calcitonin: results from two phase 3 trials
Osteoarthritis Cartilage. 2015 Apr;23(4):532-43.
This study has been identified as potentially high impact.
OE's AI-driven High Impact metric estimates the influence a paper is likely to have by integrating signals from both the journal in which it is published and the scientific content of the article itself.
Developed using state-of-the-art natural language processing, the OE High Impact model more accurately predicts a study's future citation performance than journal impact factor alone.
This enables earlier recognition of clinically meaningful research and helps readers focus on articles most likely to shape future practice.
Treatment of symptomatic knee osteoarthritis with oral salmon calcitonin: results from two phase 3 trials
Osteoarthritis Cartilage. 2015 Apr;23(4):532-43.
Osteoarthritis
The effect of oral salmon calcitonin delivered with 5-CNAC on bone and cartilage degradation in osteoarthritic patients: a 14-day randomized study
Osteoarthritis Cartilage. 2010 Feb;18(2):150-9. Epub 2009 Sep 1.
This study has been identified as potentially high impact.
OE's AI-driven High Impact metric estimates the influence a paper is likely to have by integrating signals from both the journal in which it is published and the scientific content of the article itself.
Developed using state-of-the-art natural language processing, the OE High Impact model more accurately predicts a study's future citation performance than journal impact factor alone.
This enables earlier recognition of clinically meaningful research and helps readers focus on articles most likely to shape future practice.
The effect of oral salmon calcitonin delivered with 5-CNAC on bone and cartilage degradation in osteoarthritic patients: a 14-day randomized study
Osteoarthritis Cartilage. 2010 Feb;18(2):150-9. Epub 2009 Sep 1.